These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 17241414)
1. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis. Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414 [TBL] [Abstract][Full Text] [Related]
2. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature. Vergilis-Kalner IJ J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Naumann M; Lowe NJ; Kumar CR; Hamm H; Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). Heckmann M; Ceballos-Baumann AO; Plewig G; N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190 [TBL] [Abstract][Full Text] [Related]
5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Vadoud-Seyedi J; Simonart T Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630 [TBL] [Abstract][Full Text] [Related]
6. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Heckmann M; Plewig G; Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. Simonetta Moreau M; Cauhepe C; Magues JP; Senard JM Br J Dermatol; 2003 Nov; 149(5):1041-5. PubMed ID: 14632812 [TBL] [Abstract][Full Text] [Related]
8. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. Glogau RG Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418 [TBL] [Abstract][Full Text] [Related]
9. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study. Güleç AT J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases]. Maillard H; Briand N; Bara C; Celerier P Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY; J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417 [TBL] [Abstract][Full Text] [Related]
12. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study. Grosse J; Kramer G; Jakse G BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462 [TBL] [Abstract][Full Text] [Related]
13. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis. Filosto M; Bertolasi L; Fincati E; Priori A; Tomelleri G; Chieregato G; Rizzuto N Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559 [TBL] [Abstract][Full Text] [Related]
14. Equipotent concentrations of Botox and Dysport in the treatment of palmar hyperhidrosis. Rystedt A; Swartling C; Färnstrand C; Naver H Acta Derm Venereol; 2008; 88(5):458-61. PubMed ID: 18779882 [TBL] [Abstract][Full Text] [Related]
15. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis. Absar MS; Onwudike M Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723 [TBL] [Abstract][Full Text] [Related]
17. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study. Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136 [TBL] [Abstract][Full Text] [Related]
18. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A. Bechara FG; Sand M; Achenbach RK; Sand D; Altmeyer P; Hoffmann K Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934 [TBL] [Abstract][Full Text] [Related]
19. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis. Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738 [TBL] [Abstract][Full Text] [Related]
20. Treatment of plantar hyperhidrosis with botulinum toxin type A. Vadoud-Seyedi J Int J Dermatol; 2004 Dec; 43(12):969-71. PubMed ID: 15569036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]